BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Prognosis
64 results:

  • 1. Screening for Synergistic Reagents With Pazopanib Against Osteosarcoma Using a Compound Library.
    Yada Y; Asanuma K; Kakimto T; Okuno K; Okamoto T; Iino T; Nakamura T; Sudo A
    Anticancer Res; 2024 Mar; 44(3):1071-1078. PubMed ID: 38423639
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Copy Number Gain in Androgen Receptors Predicts the Poor prognosis in Japanese Castration-resistant Prostate cancer.
    Sakamoto S; Ando K; Pae S; Zhao X; Sakai K; Sato K; Saito S; Yamada Y; Rii J; Goto Y; Sazuka T; Imamura Y; Anzai N; Akakura K; Nishio K; Ichikawa T
    Anticancer Res; 2024 Feb; 44(2):639-647. PubMed ID: 38307556
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A Systematic Review of Adjuvant Chemotherapy in Localized Dedifferentiated Chondrosarcoma.
    Tsukamoto S; Mavrogenis AF; Nitta Y; Righi A; Masunaga T; Honoki K; Fujii H; Kido A; Tanaka Y; Tanaka Y; Errani C
    Curr Oncol; 2024 Jan; 31(1):566-578. PubMed ID: 38275833
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A long-term retrospective cohort-based risk-benefit analysis of augmenting total cumulative I-131 activity to 37GBq in differentiated thyroid cancer patients with skeletal metastases.
    Kanankulam Velliangiri S; Ballal S; Prasad Yadhav M; Tripathi M; Satapathy S; Bal C
    PLoS One; 2023; 18(11):e0294343. PubMed ID: 37963164
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [The expression of neuraminidase-1 in Ewing sarcoma and its impact on sarcoma cell proliferation and migration].
    Liu BF; Gao YZ
    Zhonghua Yi Xue Za Zhi; 2023 Nov; 103(41):3287-3293. PubMed ID: 37926573
    [No Abstract]    [Full Text] [Related]  

  • 6. Ferroptosis-related lncRNAs guiding osteosarcoma prognosis and immune microenvironment.
    Yang M; Su Y; Xu K; Zheng H; Yuan Q; Cai Y; Aihaiti Y; Xu P
    J Orthop Surg Res; 2023 Oct; 18(1):787. PubMed ID: 37858131
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genomic and Transcriptomic Characterization of Gastric cancer with bone Metastasis.
    Oh S; Nam SK; Lee KW; Lee HS; Park Y; Kwak Y; Lee KS; Kim JW; Kim JW; Kang M; Park YS; Ahn SH; Suh YS; Park DJ; Kim HH
    Cancer Res Treat; 2024 Jan; 56(1):219-237. PubMed ID: 37591783
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Survival benefits and challenges of adjuvant chemotherapy for high-grade osteosarcoma: a population-based study.
    Wang J; Li M; Guo P; He D
    J Orthop Surg Res; 2023 Jun; 18(1):465. PubMed ID: 37370182
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Hypoplastic form of myelodysplastic neoplasm.
    Votavová H; Lenertová Z; Votava T; Beličková M
    Klin Onkol; 2023; 36(3):206-214. PubMed ID: 37353349
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Studies related to osteosarcoma and metabolism from 1990 to 2022: A visual analysis and bibliometric study.
    Shao Z; Bi S
    Front Endocrinol (Lausanne); 2023; 14():1144747. PubMed ID: 36950694
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Long-Term Clinical Outcomes of Patients with Colorectal cancer with Metastatic Epidural Spinal Cord Compression Treated with Hybrid Therapy (Surgery Followed by Stereotactic Body Radiation Therapy).
    Chakravarthy VB; Schachner B; Amin A; Reiner AS; Yamada Y; Schmitt A; Higginson DS; Laufer I; Bilsky MH; Barzilai O
    World Neurosurg; 2023 Jan; 169():e89-e95. PubMed ID: 36272727
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
    Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
    Front Immunol; 2022; 13():919231. PubMed ID: 35967366
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Immune contexture of paediatric cancers.
    Thakur MD; Franz CJ; Brennan L; Brouwer-Visser J; Tam R; Korski K; Koeppen H; Ziai J; Babitzki G; Ranchere-Vince D; Vasiljevic A; Dijoud F; Marec-Bérard P; Rochet I; Cannarile MA; Marabelle A
    Eur J Cancer; 2022 Jul; 170():179-193. PubMed ID: 35660252
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Pretreatment evaluation of
    Peng P; Wu N; Tao XL; Liu Y; Lyu L; Cheng X
    Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):370-376. PubMed ID: 35448927
    [No Abstract]    [Full Text] [Related]  

  • 15. Prognostic Significance of Long Non Coding RNA ANRIL and SNHG14 in Acute Myeloid Leukemia.
    Gamaleldin MA; Ghallab O; Abo Elwafa RA
    Asian Pac J Cancer Prev; 2021 Dec; 22(12):3763-3771. PubMed ID: 34967554
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Immune Dysfunction as Measured by the Systemic Immune-Inflammation Index is Associated with the Sub-Type of Minimal Residual Disease and Outcome in Stage II Colon cancer Treated with Surgery alone.
    Murray NP; Villalon R; Orrego S; Guzman E
    Asian Pac J Cancer Prev; 2021 Aug; 22(8):2391-2397. PubMed ID: 34452551
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Changing pattern of radiation therapy for bone metastases in an Australian population-based cohort of men with prostate cancer.
    Ong WL; Milne RL; Foroudi F; Millar JL
    Clin Genitourin Cancer; 2022 Feb; 20(1):e7-e15. PubMed ID: 34366292
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Do reverse total shoulder replacements have better clinical and functional outcomes than hemiarthroplasty for patients undergoing proximal humeral tumor resection using devitalized autograft composite reconstruction: a case-control study.
    Zuo D; Mu H; Yang Q; Sun M; Shen J; Wang H; Ma X; Wang C; Li C; Sun W; Cai Z
    J Orthop Surg Res; 2021 Jul; 16(1):453. PubMed ID: 34261497
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Risk factors and predictors for tumor site origin in metastatic adenocarcinoma of unknown primary site.
    Li X; Shao Y; Sheng L; Zhu J; Wang Z; Guo K; Sun L
    Cancer Med; 2021 Feb; 10(3):974-988. PubMed ID: 33405390
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Real-World Efficacy and Safety of Cabozantinib and Vandetanib in Advanced Medullary Thyroid cancer.
    Koehler VF; Adam P; Frank-Raue K; Raue F; Berg E; Hoster E; Allelein S; Schott M; Kroiss M; Spitzweg C
    Thyroid; 2021 Mar; 31(3):459-469. PubMed ID: 32781914
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 4.